StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)

Close on Nov 18, 2026Market cap $3.04BP/E –Yield –

Telix Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Telix Pharmaceuticals's price to sales ratio was 4.1× on Nov 11, 2026, against 6.6× a year earlier. Over the last 2 years it ranged from 3.8× to 18.1×, with a median of 6.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.1×−0.9
2025Dec 31, 20255.0×−10.0
2024Dec 31, 202415.0×–

More Telix Pharmaceuticals figures

See a number that looks wrong?